Language Select
Logo Varian

Press Releases

Mai 09, 2019
Following a comprehensive evaluation by Sykehusbygg HF Norway and regional health authorities, Varian (NYSE: VAR) was selected to equip two proton therapy centers in Norway with the ProBeam®... Read more
Mai 09, 2019
Varian (NYSE: VAR) today announced it has signed a strategic cooperation framework agreement with Shandong Cancer Hospital in China, for proton therapy clinical application and research. The... Read more
Mai 07, 2019
Varian (NYSE: VAR) today announced that it will be attending the UBS Global Healthcare Conference (May 20-22) and the 2019 RBC Capital Markets Healthcare Conference (May 21-22) in New York City.... Read more
Avril 30, 2019
Varian (NYSE: VAR) announced Groote Schuur Hospital in Cape Town, South Africa is the first hospital in Africa to deliver High Dose Rate (HDR) brachytherapy treatments with the Bravos™... Read more
Avril 29, 2019
Varian (NYSE: VAR) today announced Ofuna Chuo Hospital, Kamakura City, Kanagawa Prefecture, Japan is the first clinic in the country to begin treating cancer patients using the Halcyon™... Read more
Avril 26, 2019
Bringing together a global community of clinicians and scientists from leading cancer clinics to develop best practices for adaptive radiotherapy based on clinical evidence, Varian (NYSE: VAR)... Read more
Avril 24, 2019
Second Quarter 2019 Summary – Oncology gross orders grew 15% in dollars, or 18% in constant currency – Total company revenues grew 7% in dollars, or 10% in constant currency, to $779 million... Read more
Avril 23, 2019
Varian (NYSE: VAR) today announced that The Nairobi West Hospital in Nairobi, Kenya is the first clinic in the country and in West, Central, and East Africa to begin treating cancer patients using... Read more
Avril 23, 2019
Varian (NYSE: VAR) today announced it will be showcasing its new single-room proton therapy system, ProBeam® 360°, and the Bravos™ afterloader system for High Dose Rate (HDR) brachytherapy... Read more
Avril 08, 2019
Varian (NYSE: VAR) today announced the installation of the cyclotron for the Varian ProBeam® proton therapy system at Hefei Ion Medical Center (HIMC) in China. The cyclotron is a core piece of... Read more

Corporate Communications Contact

Mark Plungy
Director, Public Relations
650.424.5630
mark.plungy@varian.com

Investor Relations Contact

Mike Bruff
SVP, Investor Relations
650.424.5163
investors@varian.com